The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in December 2019 in Wuhan challenges pediatric oncologists in an unexpected way. We …

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has inflicted immense damage to countries …

Background To understand critical paediatric coronavirus disease 2019 (COVID-19) and
evaluate factors associated with mortality in children from high and low-middle income …

By means of a nationwide, prospective, multicenter, observational cohort registry collecting
data on 7375 patients with laboratory-confirmed SARS-CoV-2 admitted to children's …

Background In the pediatric population, the knowledge of the acute presentation of SARS-
CoV-2 infection is mainly limited to small series and case reports, particularly when dealing …

The ongoing COVID-19 pandemic has significantly impacted special populations, including
immunocompromised individuals, people living with HIV (PLWHIV), pediatric patients, and …

Background The new coronavirus SARS-CoV-2 pandemic has been relatively less lethal in
children; however, poor prognosis and mortality has been associated with factors such as …

Background Immunocompromised patients are at increased risk of SARS-CoV-2 infections.
Patients undergoing chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory B …

Objectives We described the etiology of severe pneumonia in children during the height of
the COVID-19 pandemic in Malaysia and compared the clinical features of severe SARS …

Importance There is limited evidence for therapeutic options for pediatric COVID-19 outside
of multisystem inflammatory syndrome in children (MIS-C). Objective To determine whether …